Revvity, Inc. (LON:0KHE)
London flag London · Delayed Price · Currency is GBP · Price in USD
94.48
+0.16 (0.17%)
At close: Jul 17, 2025

Revvity Company Description

Revvity, Inc. provides health sciences solutions, technologies, and services worldwide.

The company’s Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services.

Its Diagnostics segment offers instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions.

It also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for use in oncology, screening newborns for rare genetic conditions, immunodiagnostics, and drug discovery.

It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BioQule, BoBs, chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPatternTM, Evolution Evoya, explorer, Fontus, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Omni Bead Ruptor, Omni Bead Ruptor Elite, Omni Tip, Pannoramic, Panthera Puncher, PG-Seq, PG-Find, PreNAT II, Prime, Protein Clear, ProteinEXact, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord, VICTOR2D, and Zephyr brands.

The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023.

Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Revvity, Inc.
CountryUnited States
Founded1937
IndustryMedical - Diagnostics & Research
SectorHealthcare
Employees11,000
CEOPrahlad Singh

Contact Details

Address:
77 4th Avenue
Waltham, Massachusetts 02451
United States
Phone781 663 6900
Websiterevvity.com

Stock Details

Ticker Symbol0KHE
ExchangeLondon Stock Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS7140461093
SIC Code3826

Key Executives

NamePosition
Dr. Prahlad R. Singh Ph.D.Chief Executive Officer, President and Director
Maxwell KrakowiakSenior Vice President and Chief Financial Officer
Tajinder S. VohraSenior Vice President of Global Operations
Joel S. GoldbergSenior Vice President of Administration, General Counsel and Secretary
Miriame VictorSenior Vice President and Chief Commercial Officer
Bryan A. KippSenior Vice President of Technology and Licensing
Madhuri Hegde FACMG, Ph.D.Senior Vice President and Chief Scientific Officer
Stephen Barr WilloughbySenior Vice President of Investor Relations and Head of ESG
Magali FourSenior Vice President and Chief People and Culture Officer
Robert Francis FrielAdvisor